Kimberly-Clark offers compelling value, trading near 52-week lows, with a 5% dividend yield and a forward P/E of 13.5. The planned Kenvue merger, despite market skepticism, positions KMB as a global consumer health leader, with $32 billion in annual revenue and $1.9 billion in expected synergies. KMB maintains robust profitability, a 20.7% ROIC, an 'A' credit rating, and a well-covered dividend, with 53 consecutive years of growth.
Kraft Heinz (NASDAQ: KHC) and PepsiCo (NASDAQ: PEP) both beat Q3 2025 earnings, but the results highlight two packaged food giants on starkly different trajectories.
Jim Cramer has built his reputation around energized analysis of growth stocks and whatever is trending at the moment, mostly because that's what his audience wants to know about the most.
When you first think about a Dividend Aristocrat stock, it's likely not Canadian Natural Resources (NYSE:CNQ ).
Investors love S&P 500 dividend stocks, especially those with dependable, high yields, because they provide a substantial passive income stream and offer significant total return potential.
Microsoft stands as a premier technology investment, leveraging cloud computing, AI, and enterprise software for robust, long-term growth. MSFT delivered Q1 2026 revenue of $77.7B (+18% YoY) and non-GAAP EPS of $4.13 (+23% YoY), with a 39.6% net profit margin. The stock trades at a forward P/E of 28.1, modestly below its nine-year average, offering a potential 12% upside by end-2026.
Kimberly-Clark, an American multinational consumer goods and personal care corporation, is now a $34 billion (by market cap) consumer products leader. On November 3, Kimberly-Clark announced a $48.7 billion deal to acquire Kenvue Inc. KMB increased its dividend for 53 consecutive years, with a 10-year dividend growth rate of 4%.
T. Rowe Price has increased its dividend for 39 consecutive years. This is an esteemed Dividend Aristocrat, and it's well on its way to Dividend King status. T. Rowe Price advanced its revenue from $4.2 billion in FY 2015 to $7.1 billion in FY 2024. That's a compound annual growth rate of 6%. T. Rowe Price has a stellar financial position. The company has no long-term debt at all.
Air Products & Chemicals is a company that has displayed consistent adjusted EPS growth over the years. The company beat expectations for sales and adjusted EPS in Q3. APD's balance sheet provides it with a low cost of capital.
Hormel Foods trades near its 52-week low, offering a compelling entry for value investors with a 4.7% dividend yield. HRL demonstrates solid organic growth in retail, foodservice, and international segments, driven by strong brands and ongoing innovation. Despite margin pressure from higher input costs, HRL's transformation and modernization initiatives support long-term growth and operational efficiency.
Dividend Aristocrat stocks are great for holding your portfolio together, in good times and bad times.
BDX is now attractively valued with a forward PE of 13.7, well below its historical average, making it a compelling value stock. Strong growth in Pharmaceutical Systems and Interventional segments, margin expansion, and a robust innovation pipeline drive business momentum. The upcoming Waters Corp. spin-out will focus BDX on high-growth, recurring revenue segments, enhancing long-term earnings potential.